For pharmaceutical companies.

According to law, all medicines on the Swedish market must be released and approved for sale within the EU before they can be sold. For Tamro, as a pharmaceutical distributor, to handle and distribute a medicine, a release certificate from the pharmaceutical company holding the marketing authorisation (MAH) is required.

There are instances where pharmaceutical companies need to deliver goods that have not yet been released for sale; these must then be quarantined until EU release can take place. With extensive experience in distribution and logistics, we assist you in simplifying the process.

Here’s how it works:

We receive non-EU released goods and place them in quarantine until EU release can occur. The goods are marked with a block, making them unavailable for sale.

Once the product has been approved for release, a valid CoC (Certificate of Conformity) is required. We then manage the release of the product. The process also includes reference samples from the delivery, which are sent to you or a designated party for analysis and approval.

Do you have further questions?

Reach out to your contact person with us, or Tamro's switchboard at +46 31-767 75 00.